Unaudited Forward-Looking Statements Regarding Business Outlook | ||||||
(In millions, except per share data) | ||||||
| ||||||
Business Outlook |
| Three Months Ending June 29, 2019 | ||||
|
| GAAP Measure |
| Non-GAAP Adjustments |
| Non-GAAP Measure |
Gross margin |
| 60.0% |
| 0.50% |
| 60.5% |
|
|
|
|
|
|
|
Operating expenses |
| $112.5 |
| $23.5 |
| $89.0 |
|
|
|
|
|
|
|
Effective tax rate |
| 5.0% |
| 7.0% |
| 12.0% |
|
|
|
|
|
|
|
Diluted earnings per share - low |
| $0.16 |
| $0.54 |
| $0.70 |
|
|
|
|
|
|
|
Diluted earnings per share - high |
| $0.26 |
| $0.54 |
| $0.80 |
Silicon Laboratories Inc. | |||
Condensed Consolidated Balance Sheets | |||
(In thousands, except per share data) | |||
(Unaudited) | |||
| |||
| March 30,
|
| December 29,
|
Assets |
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents | $ 231,144 |
| $ 197,043 |
Short-term investments | 382,710 |
| 416,779 |
Accounts receivable, net | 69,871 |
| 73,194 |
Inventories | 70,489 |
| 74,972 |
Prepaid expenses and other current assets | 60,274 |
| 64,650 |
Total current assets | 814,488 |
| 826,638 |
Property and equipment, net | 138,819 |
| 139,049 |
Goodwill | 397,344 |
| 397,344 |
Other intangible assets, net | 160,512 |
| 170,832 |
Other assets, net | 110,764 |
| 90,491 |
Total assets | $1,621,927 |
| $1,624,354 |
|
|
|
|
Liabilities and Stockholders' Equity |
|
|
|
Current liabilities: |
|
|
|
Accounts payable | $ 41,544 |
| $ 41,171 |
Deferred revenue and returns liability | 23,971 |
| 22,494 |
Other current liabilities | 69,240 |
| 81,180 |
Total current liabilities | 134,755 |
| 144,845 |
Convertible debt | 358,093 |
| 354,771 |
Other non-current liabilities | 71,597 |
| 57,448 |
Total liabilities | 564,445 |
| 557,064 |
Commitments and contingencies |
|
|
|
Stockholders' equity: |
|
|
|
Preferred stock – $0.0001 par value; 10,000 shares authorized; no
| -- |
| -- |
Common stock – $0.0001 par value; 250,000 shares authorized;
| 4 |
| 4 |
Additional paid-in capital | 90,988 |
| 107,517 |
Retained earnings | 966,741 |
| 961,343 |
Accumulated other comprehensive loss | (251) |
| (1,574) |
Total stockholders' equity | 1,057,482 |
| 1,067,290 |
Total liabilities and stockholders' equity | $1,621,927 |
| $1,624,354 |